In the decade-long fight to control CRISPR, the super-tool for modifying DNA, it’s been common for lawyers to try to overturn patents held by competitors by pointing out errors or inconsistencies.
But now, in a surprise twist, the team that earned the Nobel Prize in chemistry for developing CRISPR is asking to cancel two of their own seminal patents, MIT Technology Review has learned. The decision could affect who gets to collect the lucrative licensing fees on using the technology. Continue here.
If you do need a website or your business needs a website, we’re here to bring your dreams to live. Contact us. We would give you the best in quality and the most affordable you would get on the market place. Enjoy our 100% refundable deals. You can’t loose let’s talk about your project.
Kindly reach out on WhatsApp directly and let’s make this decision your most important and best investment post 3 years.
Disclaimer: Full credit to the writer, and the associates.
